MedTrace Logo

The Impact of Delflex on Mesothelial Cell Viability and Peritoneal Transport

NCT01292863 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2013-02-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the impact of Delflex neutral pH (a biocompatible peritoneal dialysis solution) on mesothelial cell viability and peritoneal transport.

Conditions

Interventions

OTHER

Active Comparator: Conventional peritoneal dialysis solution

Daily dialysis solution to be used for 3 months in crossover fashion.

OTHER

Experimental: Novel biocompatible dialysis solution

Daily dialysis solution to be used for 3 months in crossover fashion.

Sponsors & Collaborators

  • Fresenius Medical Care North America

    collaborator INDUSTRY

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Cynthia J Denu-Ciocca, MD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-02-29
Completion
2012-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01292863 on ClinicalTrials.gov